Back to mobile site

WAVE Life Sciences (WVE) Reiterated at Overweight by Cantor Fitzgerald on WVE-006 Data

May 19, 2026 6:56 AM EDT Send to a Friend
Cantor Fitzgerald analyst Steve Seedhouse reiterated an Overweight rating and $13.00 price target on WAVE Life Sciences (NASDAQ: WVE).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login